Skip to main content
. 2022 May 11;11(10):2721. doi: 10.3390/jcm11102721

Table 4.

Haemostatic treatments.

Treatment n (%) Doses (U)
Range Median IQR
Recombinant FVIIa 15 (57.70) 5–670 70.00 27–151
aPCC 3 (11.50) 42,000–150,000 124,000 *
Human FVIII 25 (96.10) 5000–722,000 111,000 63,000–205,000

IQR, interquartile range. * Not calculated for the number of events. FVIIa, activated recombinant Factor VII; aPCC, activated prothrombin complex concentrate; FVIII: Factor VIII.